Skip to NavigationSkip to content

Cephalon chairman takes leave of absence

Published on: 02/09/10

Cephalon’s chairman and chief executive Frank Baldino Jr is taking a medical leave of absence with immediate effect.

The company said he was expected to return to helm the company later this year.

Meanwhile Cephalon’s chief operating officer J Kevin Bushi will temporarily take on Frank’s responsibilities.

Prior to assuming the newly-created role of chief operating officer earlier this year, Mr Buchi served as the company's chief financial officer for 14 years, and in total has been with Cephalon for almost 20 years.

William Egan, Cephalon's presiding director, said, "Kevin has the complete confidence and full support of the board as he manages the company's operations until Frank's anticipated return later this year.

"In order to provide Frank and his family the privacy that they deserve, we will not be commenting further."

Mission Statement
InPharm.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma jobs, pharma events, and pharma service company listings.
Site content is produced by our editorial team for InPharm.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
a site by SiftGroups